Novo Nordisk (NVO +1.84%) has sparked investor interest primarily because of its weight loss treatments.
*Stock prices used were the afternoon prices of Jan. 2, 2025. The video was published on Jan. 4, 2025.
Is Novo Nordisk an Undervalued Stock to Buy Now?
By Parkev Tatevosian, CFA – Jan 6, 2025 at 4:30AM EST
NYSE: NVO
Novo Nordisk
Market Cap
$174B
Today's Change
(1.84%) $0.95
Current Price
$52.56
Price as of December 24, 2025 at 1:00 PM ET
Read Next
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Stocks Mentioned
Novo Nordisk
NYSE: NVO
$52.56 (+0.02%) $+0.95
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Advertisement